TikTok resumes operations in the U.S. after President-elect Trump promises a 90-day extension to the divest-or-sell law, ...

Dan Ives, Wedbush Securities global head of tech research, joins CNBC's 'The Exchange' to discuss the looming TikTok ban in ...

Wedbush downgraded Keros Therapeutics (KROS) to Neutral from Outperform with a price target of $15, down from $47. The firm has removed cibotercept for pulmonary arterial hypertension from the ...

Shake Shack Inc. (NYSE:SHAK – Free Report) – Wedbush boosted their Q4 2024 EPS estimates for shares of Shake Shack in a research note issued to investors on Wednesday, January 15th.

Wedbush currently has a “Outperform” rating and a $34.00 target price on the stock. The consensus estimate for Kiniksa Pharmaceuticals’ current full-year earnings is ($0.55) per share.

Wedbush downgraded Keros Therapeutics (KROS) to Neutral from Outperform with a $15 price target after removing pulmonary arterial hypertension and obesity programs from the firm’s model.

Investing.com -- Wedbush upgraded PulteGroup Inc (NYSE:PHM) to "outperform" from "neutral" given an overdone stock price decline and strong catalysts for growth. Shares were up 2.1% at $110.

VICI Properties Inc (VICI) stock saw a modest uptick, ending the day at $29.35 which represents a slight increase of $0.07 or 0.24% from the prior close of $29.28. The stock opened at $29.33 and ...

The popular platform could be banned on Jan. 19 under a federal law, while many parties have expressed interest in buying the ...

Netflix is set to report fourth-quarter results after the closing bell on Tuesday, with Wall Street analysts holding mostly ...

Tesla ( TSLA) stock jumped 3% Friday amid speculation that CEO Elon Musk could potentially buy TikTok. The social media ...